Luclinicare
ActiveLuclinicare has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €22k and a net result of €52k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 19% of 31642 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
64
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency39▼-37
Growth58▼-20
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days acceptable
Liquidity tight (current ratio 1.01 against 1.89 in 2024; short-term debt: 86.3% and cash: 25.2% of total assets), and 86.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
13.7%
Return on assets
32.9%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 31642 sector peers (2025).
NBB · sector comparisonPosition among 31642 sector peers
Solvency
better than 19%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
32 d early
2024
22 d late
2023
31 d late
2022
9 d late
2021
4 d early
2020
88 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€22k▼ 78.0%
2024 · €99k
2020: €25k
2021: €35k
2022: €113k
2023: €129k
2024: €99k
2020 → 2025
Total assets
€159k▼ 18.8%
2024 · €196k
2020: €73k
2021: €64k
2022: €146k
2023: €211k
2024: €196k
2020 → 2025
Net result
€52k▼ 13.0%
2024 · €60k
2020: €24k
2021: €11k
2022: €77k
2023: €66k
2024: €60k
2020 → 2025
Working capital
€976▼ 98.9%
2024 · €86k
2020: €19k
2021: €32k
2022: €104k
2023: €116k
2024: €86k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€35k-€113k▲ 218%€129k▲ 14.5%€99k▼ 23.0%€22k▼ 78.0%
Operating result€17k-€99k▲ 484%€88k▼ 11.5%€74k▼ 16.3%€64k▼ 12.6%
Net result€11k-€77k▲ 610%€66k▼ 14.1%€60k▼ 9.1%€52k▼ 13.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen three years in a row; 2025 is 13% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €159k
Fixed assets
€21k▲ 58.7%
Current assets
€138k▼ 24.3%
Equity and liabilities €159k
Equity
€22k▼ 78.0%
Debt
€138k▲ 42.1%
The debt ratio rises from 49.3% to 86.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€69k▼
2024 · €79k
Cash flow
€57k▼
2024 · €66k
Solvency
13.7%▼
2024 · 50.7%
Current ratio
1.01▼
2024 · 1.89
Quick ratio
1.01▼
2024 · 1.89
Debt / equity
6.29▲
2024 · 0.97
ROE
240.0%▲
2024 · 60.7%
ROA
32.9%▲
2024 · 30.7%
Interest coverage
548.90▼
2024 · 635.50
Debt
€138k▲
2024 · €97k
Debt ≤ 1 year
€138k▲
2024 · €97k
Income taxes
€16k▼
2024 · €18k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€196k€159k▼
Fixed assets21/28€13k€21k▲
Tangible fixed assets22/27€13k€21k▲
Furniture and vehicles24€9k€12k▲
Other tangible fixed assets26€4k€8k▲
Current assets29/58€183k€138k▼
Amounts receivable after more than one year29€86k€75k▼
Trade receivables290€86k€75k▼
Amounts receivable within one year40/41€19k€19k▼
Trade receivables40€16k€16k=
Other amounts receivable41€3k€2k▼
Cash at bank and in hand54/58€77k€40k▼
Deferred charges and accrued income490/1€968€5k▲
Equity and liabilities
Total equity and liabilities10/49€196k€159k▼
Equity10/15€99k€22k▼
Contributions10/11€250€250=
Profit (loss) carried forward14€99k€22k▼
Amounts payable17/49€97k€138k▲
Amounts payable within one year42/48€97k€138k▲
Trade debts44€3k€4k▲
Suppliers440/4€3k€4k▲
Taxes, remuneration and social security45€3k€76▼
Taxes450/3€71€76▲
Remuneration and social security454/9€3k-
Other amounts payable47/48€91k€133k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€5k▼
Other operating charges640/8€3k€656▼
Gross operating margin9900€82k€70k▼
Operating profit (loss)9901€74k€64k▼
Financial income75/76B€5k€4k▼
Recurring financial income75€5k€4k▼
Financial charges65/66B€125€126▲
Recurring financial charges65€125€126▲
Profit (loss) for the period before taxes9903€79k€69k▼
Income taxes67/77€18k€16k▼
Profit (loss) for the period9904€60k€52k▼
Profit (loss) for the period to be appropriated9905€60k€52k▼
Appropriation of the result
Profit (loss) to be appropriated9906€189k€152k▼
Profit (loss) brought forward from the previous period14P€129k€99k▼
Profit to be distributed694/7€90k€130k▲
Return on contributions (dividend)694€90k€130k▲
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
22-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 22 days late
2024
31-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 31 days late
2023
09-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 9 days late
2022
31-12
Financial
Highest result since 2020net €77k ▲610%
Operating result €99k, net result €77k, both a record.
31-12
Financial
Equity above €100kEq €113k ▲218%
3 profitable years in a row build equity to €113k.
27-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Weakest financial yearnet €11k ▼55.1%
Net result drops to €11k, the lowest in the series; recovery starts the following year.
27-10
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 88 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Overijse · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Sint-Hubertusdreef 413090 OverijseGround area
1,355 m²
Building footprint
234 m²
Volume, LiDAR
1,090 m³
Parcel 23062M0070/00W005, Flanders · tallest building 8.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Luclinicare
since 20202.305.426.120
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23062M0070/00W005 | Flanders | 1,355 m² | 1 · 234 m² | 8.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
THI-CON
BE 1028.174.264
Brugge · Eq €22k
Impact Management
BE 0782.317.767
Gent · Eq €22k
D-Metis
BE 1030.650.140
Mont-Saint-Guibert · Eq €22k
HESTIA
BE 0563.871.490
Rixensart · Eq €22k
CONSULT-INN
BE 0713.908.617
Anderlecht · Eq €22k
Of 82,570 companies in sector 70200 we hold annual accounts for 52,573. 31,531 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded23-07-2020
Fiscal year end31-12
Activities, NACEBEL
70200Business and other management consultancy
70220Business consulting
72101Research and development on biotechnology
73110Advertising agencies
73200Market research and public opinion polling
74909Other professional, scientific and technical activities
74999Other professional, scientific and technical activities
82100Office administrative and support services
82110Office administrative, office support and other business support activities
82190Office administrative, office support and other business support activities
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.